On 2026-03-09, Boundless Bio, Inc. (BOLD) announced earnings per share of $-0.58 for the fiscal quarter ending 2025-12-31, missing the average analyst estimate of $-0.44.
The next expected annoucement date for quarterly earnings is 2026-05-08, with an average estimated earnings per share of $-0.51 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-03-09 | 2025-12-31 | $-0.44 | $-0.58 |
| 2025-11-05 | 2025-09-30 | $-0.53 | $-0.62 |
| 2025-08-05 | 2025-06-30 | $-0.75 | $-0.70 |
| 2025-05-09 | 2025-03-31 | $-0.68 | $-0.71 |
| 2025-03-27 | 2024-12-31 | $-0.74 | $-0.74 |
| 2024-11-07 | 2024-09-30 | $-0.76 | $-0.74 |
| 2024-08-12 | 2024-06-30 | $-0.78 | $-0.77 |
| 2024-05-13 | 2024-03-31 | $-0.65 | $-12.27 |